Envíe este artículo por correo electrónico 
Ocultar
Mostrar todos
Prevención de la sarcopenia en pacientes con enfermedad de Parkinson: Revisión descriptiva desde la medicina preventiva
Resumen
Resumen: La enfermedad de Parkinson ocupa el segundo lugar de las enfermedades neurodegenerativas más comunes en el mundo. La sarcopenia se caracteriza por dinapenia y en los adultos mayores con diagnóstico de enfermedad de Parkinson acelera su progresión. El objetivo de la presente revisión es describir el estado sarcopénico y la importancia de su prevención en los adultos mayores con enfermedad de Parkinson, así como ofrecer una revisión de las medidas de prevención primaria, secundaria y terciaria pertinentes para su abordaje. Si bien el deterioro y la gravedad de la enfermedad de Parkinson se relaciona directamente con el estado sarcopénico del paciente mediante el abordaje disciplinario, la medicina preventiva puede favorecer la calidad de vida de los pacientes mediante medidas de promoción, diagnóstico oportuno, tratamiento farmacológico y no farmacológico y limitación de la progresión de la sarcopenia.
Abstract: Parkinson's disease ranks second among the most common neurodegenerative diseases in the world. Sarcopenia is characterized by dynapenia and in older adults diagnosed with Parkinson's disease accelerates its progression. The objective of the present review is to describe the sarcopenic state and the importance of its prevention in older adults with Parkinson's disease, as well as to offer a review of primary prevention measures, secondary and tertiary relevant to its approach. Although the deterioration and severity of Parkinson's disease is directly related to the sarcopenic state of the patient through the disciplinary approach, preventive medicine can favor the quality of life of patients through promotional measures, timely diagnosis, pharmacological treatment and not pharmacological and limiting the progression of sarcopenia.
Referencias
Martínez FR, Gasca SC, Sánchez FÁ, Obeso JA. Actualización en la enfermedad de Parkinson. Rev Med Clin Condes. 2016;27(3):363-79. doi: 10.1016/j.rmclc.2016.06.010
Moreno CB, Hernández BN, Munévar D, Gutiérrez AM. Dolor neuropático central en enfermedad de Parkinson. Neurología. 2011. doi: 10.1016/j.nrl.2011.08.001
Navarro RC, Rodríguez VM, Cervantes AA. Terapias de infusión en la enfermedad de Parkinson avanzada. Rev Mex Neuroci. 2019;20(1):3-13. doi: 10.24875/RMN.M19000018
T, Mao X, Park H. Poly (ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson's disease. Mov Disord Clin Pract. 2019;6(3):199. doi: 10.1002/mdc3.12727
Xiao Y, Lau JC, Hemachandra D, Gilmore G, Khan A, Peters TM. Image guidance in deep brain stimulation surgery to treat Parkinson's disease: a comprehensive review. IEEE Trans Biomed Eng. 2020. doi: 10.1109/TBME.2020.3006765
Diagnóstico y tratamiento de la Enfermedad de Parkinson inicial y avanzada en el tercer nivel de atención, México: Secretaría de Salud, 2010.
Chávez DV, Infante SH, Serralde AE. Sarcopenia y funcionalidad en el adulto mayor hospitalizado. Nutr Hosp. 2015;31(4):1660-66. doi: 10.3305/nh.2015.31.4.8502
Yazar T, Yazar HO, Zayimoğlu E, Çankaya S. Incidence of sarcopenia and dynapenia according to stage in patients with idiopathic Parkinson’s disease. Neurol Sci. 2018;39(8):1415-21. doi: 10.1007/s10072-018-3439-6
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39(4):412-23. doi: 10.1093/ageing/afq034
Vetrano DL, Pisciotta MS, Laudisio A, Lo Monaco MR, Onder G, Brandi V, et al. Sarcopenia in Parkinson Disease: Comparison of Different Criteria and Association With Disease Severity. J Am Med Dir Assoc. 2018;19(6):523-27. doi: 10.1016/j.jamda.2017.12.005
Lai CH, Chen HC, Liou TH, Li W, Chen SC. Exercise Interventions for Individuals with Neurological Disorders: A Systematic Review of Systematic Reviews. Am J Phys Med Rehabil. 2019; 98(10):921-30. doi: 10.1097/PHM.0000000000001247
Rendón-Rodríguez R, Osuna-Padilla IA. El papel de la nutrición en la prevención y manejo de la sarcopenia en el adulto mayor. Nutr Clin Med. 2018;12(1):23-36. doi: 10.7400/NCM.2018.12.1.5060
Poehlman ET, Toth MJ, Fishman PS, Vaitkevicius P, Gottlieb SS, Fisher ML, et al. Sarcopenia in aging humans: the impact of menopause and disease. J Gerontol A Biol Sci Med Sci. 1995; 50:73-7. doi: 10.1093/gerona/50a.special_issue.73
Ali S, Garcia JM. Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review. Gerontology. 2014;60(4):294-305. doi: 10.1159/000356760
Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB. Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. J Am Med Dir Assoc. 2011; 12(4):249-56. doi: 10.1016/jamda.2011.01.003
Zhao J, Brault JJ, Schild A. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab. 2007;6:472-83. doi:10.1016/j. cmet.2007.11.004
Beasley JM, Shikany JM, Thomson CA. The role of dietary protein intake in the prevention of sarcopenia of aging. Nutr Clin Pract. 2013;28(6):684-90. doi: 10.1177/0884533613507607
Drummond MJ, Addison O, Brunker L, Hopkins PN, McClain DA, LaStayo PC, et al. Downregulation of E3 ubiquitin ligases and mitophagy-related genes in skeletal muscle of physically inactive, frail older women: a cross-sectional comparison. J Gerontol A Biol Sci Med Sci. 2014; 69(8):1040-48. doi: 10.1093/gerona/glu004
Joseph AM, Adhihetty PJ, Buford TW. The impact of aging on mitochondrial function and biogenesis pathways in skeletal muscle of sedentary high- and low-functioning elderly individuals. Aging Cell. 2012;11(5):801-9. doi: 10.1111/j.1474-9726.2012. 00844.x
Fry CS, Drummond MJ, Glynn EL, Dickinson JM, Gundermann DM, Timmerman KL, et al. Skeletal muscle autophagy and protein breakdown following resistance exercise are similar in younger and older adults. J Gerontol A Biol Sci Med Sci. 2013; 68:599–607. doi: 10.1093/gerona/gls209
Vetrano DL, Landi F, Volpato S, Corsonello A, Meloni E, Bernabei R, et al. Association of sarcopenia with shortand long-term mortality in older adults admitted to acute care wards: Results from the crime study. J Gerontol Ser A Biol Sci Med Sci 2014;69:1154-61. doi: 10.1093/gerona/glu034
Peball M, Mahlknecht P, Werkmann M, Marini K, Murr F, Herzmann H, Willeit P. Prevalence and associated factors of sarcopenia and frailty in Parkinson’s disease: a cross-sectional study. Gerontology 2019;65(3):216-28. doi:10.1159/000492572
Ozer FF, Akın S, Gultekin M, Zararsız GE. Sarcopenia, dynapenia, and body composition in Parkinson’s disease: are they good predictors of disability? A case–control study. Neurological Sciences 2020;41(2):313-20. doi: 10.1007/s10072-019-04073-1
Bian A, Ma Y, Zhou X, Guo Y, Wang W, Zhang Y, et al. Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly. BMC Musculoskelet Disord. 2020; 21:14. doi: 10.1186/s12891-020-03236-y
Basualto-Alarcón C, Varela D, Duran J, Maass R, Estrada M. Sarcopenia and Androgens: A Link between Pathology and Treatment. Front Endocrinol (Lausanne). 2014; 5:217. doi: 10.3389/fendo.2014.00217
Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R. Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies, J Diabetes Metab Disord. 2017; 16:21. doi: 10.1186/s40200-017-0302-x
García AA, García BF. La medicina preventiva en la atención primaria de salud. Rev. Haban Cienc Med. 2012;11(2):308-16.
Valenzuela RER, Ponce JA, Morales-Figueroa GG, Muro KA, Carreón VR, Alemán-Mateo H. Insufficient amounts and inadequate distribution of dietary protein intake in apparently healthy older adults in a developing country: implications for dietary strategies to prevent sarcopenia. Clin Interv Aging. 2013; 8:1143-48. doi: 10.2147/CIA.S49810
Beaudart C, Dawson A, Shaw SC, Harvey NC, Kanis JA, Binkley N, et al. Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review. Osteoporos Int. 2017; 28(6):1817-33. doi: 10.1007/s00198-017-3980-9.
Naseeb MA, Volpe SL. Protein and exercise in the prevention of sarcopenia and aging. Nutr Res. 2017; 40:1-20. doi: 10.1016/j.nutres.2017.01.001
Granic A, Dismore L, Hurst C, Robinson SM, Sayer AA. Myoprotective Whole Foods, Muscle Health and Sarcopenia: A Systematic Review of Observational and Intervention Studies in Older Adults. Nutrients. 2020;12(8):2257. doi: 10.3390/nu12082257.
Wirth R, Dziewas R, Jäger M, Warnecke T, Smoliner C, Stingel K, et al. Clinical Nutrition in Neurology – Part of the Ongoing S3-Guideline Project Clinical Nutrition. Aktuel Ernahrungsmed. 2013;38(4): e49-e89. doi: 10.1055/s-0033-1343317 (Alemán)
Gao X, Chen H, Fung TT, Logroscino G, Schwarzschild MA, Hu FB, et al. Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr. 2007;86(5):1486-94. doi: 10.1093/ajcn/86.5.1486
Alcalay RN, Gu Y, Mejia SH, Cote L, Marder KS, Scarmeas N. The association between Mediterranean diet adherence and Parkinson’s disease. Mov Disord. 2012;27(6):771-4. doi: 10.1002/mds.24918
Robinson SM, Reginster JY, Rizzoli R, Shaw SC, Kanis JA, Bautmans I, et al. Does nutrition play a role in the prevention and management of sarcopenia? Clin Nutr. 2018;37(4):1121-32. doi: 10.1016/j.clnu.2017.08.016
Wu H, Xia Y, Jiang J, Du H, Guo X, Liu X, et al. Effect of beta-hydroxy-beta-methylbutyrate supplementation on muscle loss in older adults: a systematic review and meta-analysis. Arch Gerontol Geriatr. 2015;61(2):168-75. doi:10.1016/j. archger.2015.06.020
Reynaldo CLE, González GY, Rodríguez LR. Adherencia a programas de rehabilitación física como tratamiento efectivo en enfermedades neurodegenerativas. Revista científica especializada en Cultura Física y Deportes. 2019;17(43):129-40.
Nascimento CM, Ingles M, Salvador PA, Cominetti MR, Gomez CMC, Viña J. Sarcopenia, frailty and their prevention by exercise. Free Radical Biology and Medicine. 2019; 132:42-9. doi: 10.1016/j.freeradbiomed.2018.08.035
Xu Z, Tan Z, Zhang Q, Gui Q, Yang Y. Clinical Effectiveness of Protein and Amino Acid Supplementation on Building Muscle Mass in Elderly People : A Meta-Analysis. PloS One. 2014; 9(9). doi: 10.1371/journal.pone.0109141
Yu R, Wong M, Leung J, Lee J, Auyeung TW, Woo J. Incidence, reversibility, risk factors and the protective effect of high body mass index against sarcopenia in community-dwelling older Chinese adults. J Nutr Health Aging. 2016; 14:15–28. doi: 10.1007/s12603-016-0704-3
Tello-Rodríguez, Alarcón, RD, Vizcarra-Escobar D. Salud mental en el adulto mayor: trastornos neurocognitivos mayores, afectivos y del sueño. Rev Peru Med Exp Salud Publica. 2016;33(2):342-50. doi: 10.17843/rpmesp.2016.332.2211
Naranjo JEG, Alfonso MA, Delgado AIC, Chacón LMM, Rodriguez A. Trastornos del sueño en pacientes con enfermedad de Parkinson. Rev Cubana Neurol Neurocir. 2020;10(1). doi: 10.3390/bs9010006
Ospina GN. Trastornos del sueño y dolor en la enfermedad de Parkinson. Acta Neurológica Colombiana. 2019; 35:63-8. doi: 10.22379/24224022251
Li SX, Lam SP, Zhang J, Yu MW, Chan JW, Liu Y, et al. A prospective, naturalistic follow-up study of treatment outcomes with clonazepam in rapid eye movement sleep behavior disorder. Sleep Med. 2016; 21:114-20. doi: 10.1016/j.sleep.2015.12.020
McCarter SJ, Boswell CL, St Louis EK, Dueffert LG, Slocumb N, Boeve BF, et al. Treatment outcomes in REM sleep behavior disorder. Sleep Med. 2013;14(3):237-42. doi: 10.1016/j.sleep.2012.09.018
Menza M, Dobkin RD, Marin H, Gara M, Bienfait K, Dicke A, et al. Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placebo. Mov Disord. 2010;25(11):1708-14. doi: 10.1002/mds.23168
Karlsen KH, Larsen JP, Tandberg E, Maland JG. Influence of clinical and demographic variables on quality of life in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1999;66(4):431-5. doi: 10.1136/jnnp.66.4.431
Rodríguez-Violante M, Zerón-Martínez R, Cervantes-Arriaga A. Complejo sintomático no motor de la enfermedad de Parkinson. Neurología, Neurocirugía y Psiquiatría. 2017;45(2):51-60.
Taekema DG, Gussekloo J, Maier AB, Westendorp RG, Craen AJ. Handgrip streght as a predictor of functional, psychological and social health A prospective population-base study among the oldest old. Age Ageing. 2010; 39:331-7. doi: 10.1093/ageing/afq022
Cruz-Jentoft AJ, Landi F, Topinkova E, Michel JP. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2010;13(1):1-7. doi: 10.1097/MCO.0b013e328333c1c1
Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998; 147(8):755-63. doi: 10.1093/oxfordjournals.aje.a009520
Bioelectrical impedance analysis in body composition measurement: National Institutes of Health Technology Assessment Conference Statement. Am J Clin Nutr. 1996;64(3):524S-32S. doi: 10.1093/ajcn/64.3.524S
Wielopolski L, Ramirez LM, Gallagher D, Heymsfield SB, Wang ZM. Measuring partial body potassium in the arm versus total body potassium. J Appl Physiol. 2006;101(3):945-49. doi: 10.1152/japplphysiol.00999.2005
Rolland Y, Lauwers CV, Cournot M, Nourhashémi F, Reynish W, Riviere D, et al. Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study. J Am Geriatr Soc. 2003; 51(8):1120-24. doi: 10.1046/j.1532-5415.2003. 51362.x
Laurentani F, Russo C, Bandinelli S, Bartali B, Cavazzini C, Di Lorio A, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95(5):1851-60. doi: 10.1152/japplphysiol.00246.2003
Al Snih S, Markides K, Ottenbacher K, Raji M. Hand grip strength and incident ADL disability in elderly Mexican Americans over a seven-year period. Aging Clin Exp Res. 2004;16(6):481-6.
Foldvari M, Clark M, Laviolette LC, Bernstein MA, Kaliton D, Castaneda C, et al. Association of muscle power with functional status in community-dwelling elderly women. J Gerontol A Biol Sci Med Sci. 2000;55(4):M192-199. doi: 10.1093/gerona/55.4.m192
Working Group on Functional Outcome Measures for Clinical Trials. Functional outcomes for clinical trials in frail older persons: time to be moving. J Gerontol A Biol Sci Med Sci. 2008;63(2):160-4. doi: 10.1093/gerona/63.2.160
Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85–94. doi: 10.1093/geronj/49.2.m85
Buchner DM, Larson EB, Wagner EH, Koepsell TD, de Lateur BJ. Evidence for a non-linear relationship between leg strength and gait speed. Age Ageing. 1996;25(5):386-91. doi: 10.1093/ageing/25.5.386
Mathias S, Nayak US, Isaacs B. Balance in elderly patients: the “get-up and go” test. Arch Phys Med Rehabil. 1986;67(6):387-9.
Morley J. Treatment of sarcopenia: the road to the future. J Cachexia Sarcopenia Muscle. 2018;9(7):1196-99. doi: 10.1002/jcsm.12386
Dhillon R, Hasni S. Pathogenesis and Management of Sarcopenia. Clin Geriatr Med. 2017;33(1):17-26. doi: 10.1016/j.cger.2016.08.002
Marras C, Chaudhuri KR, Titova N, Mestre TA. Therapy of Parkinson's Disease Subtypes. Neurotherapeutics. 2020 Aug 4. doi: 10.1007/s13311-020-00894-7
Xiao Y, Lau JC, Hemachandra D, Gilmore G, Khan A, Peters TM. Image guidance in deep brain stimulation surgery to treat Parkinson's disease: a comprehensive review. IEEE Trans Biomed Eng. 2020 Jul 2;PP. doi: 10.1109/TBME.2020.3006765
Henwood TR, Taaffe DR. Detraining and retraining in older adults following long-term muscle power or muscle strength specific training. J Gerontol A Biol Sci Med Sci. 2008;63(7):751-8. doi: 10.1093/gerona/63.7.751
Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, et al. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc. 2011;12(6):403-9. doi: 10.1016/j.jamda.2011.04.014
Yoshimura Y, Wakabayashi H, Yamada M, Kim H, Harada A, Arai H. Interventions for Treating Sarcopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. J Am Med Dir Assoc. 2017;18(6):553. doi: 10.1016/j.jamda.2017.03.019
Csoti I, Dresel C, Hauptmann B, Müller T, Redecker C, Warnecke T, et al. Nutritional aspects in Parkinson's disease: disease risk, dietary therapy and treatment of digestive tract dysfunction. Fortschr Neurol Psychiatr. 2018;86(S01):S34-S42. doi: 10.1055/a-0681-6700 (Alemán)
Aguilar-Parra JM, Gallego J, Fernández-Campoy JM, Pérez-Gallardo ER, Trigueros R, et al. Influencia de programas de actividad física en la calidad del sueño de personas mayores de 55 años. RPD. 2015;24(2):289-95.
Rendón OMC, Rodríguez LMA. Valoración clínica geriátrica integral en medicina familiar. Rev Med Inst Mex Seguro Soc 2011;49(2):171-7.
Sequeira FMM. Nivel de conocimiento del médico familiar sobre la Valoración Geriátrica Integral en la Unidad de Medicina Familiar No. 1 de Aguascalientes. Tesis para obtener el grado de especialista en Medicina Familiar. Universidad Autónoma de Aguascalientes. Aguascalientes.2018 Feb 2018. México.
Enlaces refback
- No hay ningún enlace refback.
